Erythroderma following the intradermal injection of the corticosteroid budesonide.
Wilkinson
S M
SM
Dermatology Department, North Staffordshire Hospital Centre, Stoke-on-Trent, UK.
Smith
A G
AG
English
J S
JS
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D019819:Budesonide; D003429:Cross Reactions; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005938:Glucocorticoids; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D011282:Pregnenediones / Q000008:administration & dosage / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide